logo-loader
viewTHC Global Group Ltd

THC Global Group Queensland cannabis production facility opened by Australian Health Minister Greg Hunt

The Southport production facility is the largest bio-floral pharma extraction facility in the Southern Hemisphere.

THC Global Group Ltd -
THC Global chairman Steven Xu, Rob Molhoek MP, Minister for Health Greg Hunt, Angie Bell MP and THC Global CEO Ken Charteris

THC Global Group Limited (ASX:THC) rolled out the welcome mat for Australian Health Minister Greg Hunt yesterday as the parliamentarian opened the group’s large pharmaceutical manufacturing facility in Southport on Queensland’s Gold Coast.

This facility is capable of large-scale extraction of pharma-grade Good Manufacturing Practice (GMP) certified Active Pharmaceutical Ingredient (API) and THC hopes to see it used for biotechnology, agricultural technology and medicinal research and development.

Minister Hunt was joined at the security-controlled event by Federal Member for Moncrieff Angie Bell and Queensland State Member for Southport Rob Molhoek.

THC is looking to connect with academics across Australia and in Queensland who are interested in using the facility for their research.

Annual output for the facility has been set at a conservative 12,000 kilograms of GMP-certified API.

The company has highlighted its output capacity exceeded demand in the Australian market where the Federal Government expects prescriptions will number 100,000 prescriptions in the near term.

THC expects its extra production capacity will enable it to target the international cannabis market so it can better reach capacity.

By having a local cannabis facility, the high costs Australian THC-product consumers pay for products currently imported from abroad may come down to more accessible levels.

THC has told the market it hopes to help bring down costs for Australians by early 2020, saying “THC Global is in prime position with its primary cultivation, processing, and manufacturing assets of commercial-scale secured and ready to commence operating at low cost.

“[This will enable] access to Australian patients at a better price, and [make] Australia a prime exporter of medicinal cannabis products of the highest safety and quality standards.”

Cannabis products player THC is pursuing a vertically-integrated farm-to-pharma approach for its commercialisation as a group.

The group expects to be the first commercial-scale Australian supplier of Australian-produced medicinal cannabis products.

Quick facts: THC Global Group Ltd

Price: 0.39 AUD

ASX:THC
Market: ASX
Market Cap: $53.5 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of THC Global Group Ltd named herein, including the promotion by the Company of THC Global Group Ltd in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

THC Global granted manufacturing licence by Australian Office of Drug Control

THC Global Group Ltd (ASX:THC) chief executive officer Ken Charteris updates Proactive Investors on the manufacturing licence granted to the cannabis company by the Australian Office of Drug Control.   "It's a significnat milestone ... we now are a farm-to-pharma process which...

on 06/12/2019

2 min read